Mechanism of action
Somatrogon-ghla binds to the GH receptor and initiates a signal transduction cascade culminating in changes in growth and metabolism.
General use cases
- Growth Disorders
- pediatric patients aged 3 years and older who have growth failure due to an inadequate secretion of endogenous growth hormone
- pediatric patients aged 3 years and older who have growth failure due to inadequate secretion of endogenous growth hormone ( 1 )
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
